Investigating characteristics and treatment of male breast cancer in China
The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
This study looks at the details and treatment of male breast cancer in China to see how different factors affect patients' outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | First Affiliated Hospital, Sun Yat-Sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06220630 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the characteristics, treatment patterns, and prognosis of male breast cancer (MBC) patients in China. Researchers will extract clinicopathological data, treatment information, and follow-up data from a national database and various Chinese medical centers. The study will analyze factors such as survival time, diagnosis year, age, cancer stage, molecular subtype, histology, and treatment modalities used. By understanding these factors, the study seeks to provide insights into the unique aspects of MBC in the Chinese population.
Who should consider this trial
Good fit: Ideal candidates for this study are male patients who have been microscopically diagnosed with primary breast cancer.
Not a fit: Patients with skin-origin malignancies on the breast will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of male breast cancer in China, leading to improved treatment strategies and patient outcomes.
How similar studies have performed: While there may be limited studies focusing specifically on male breast cancer in China, similar observational studies have shown success in understanding cancer characteristics and treatment patterns in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological sex is male; * Microscopically diagnosed as primary breast cancer. Exclusion Criteria: * Presence of skin-origin malignancy on the breast.
Where this trial is running
Guangzhou, Guangdong
- First affiliated hospital of Sun Yat-sen university — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Principal investigator: Ying Lin, MD, PhD — 1st affiliated hospital of Sun Yat-sen university
- Study coordinator: Yuxuan Gao, MD
- Email: gaoyx9@mail2.sysu.edu.cn
- Phone: +86 18142846375
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.